NVLG: Revenue fell and net loss recorded in 2025, mainly due to SAP rollout disruptions in logistics

About this update from Novolog (pharm Up 1966) Ltd.

2025 saw a revenue decline and net loss due to SAP system rollout disruptions in logistics, offset by growth in health and digital segments. Strategic divestments and efficiency measures were implemented, with no additional financing needs anticipated for 2026. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Novolog (pharm Up 1966) Ltd.